BioIVT continues biospecimen buy up with Keystone Biologicals deal

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/Fly_dragonfly)
(Image: Getty/Fly_dragonfly)
The provider research models and services, BioIVT, has acquired Hatboro-PA-based Keystone Biologicals, which supplies disease-state plasma, sera, and controls.

BioIVT​ Vice President of Marketing Courtney Noah, PhD, said the acquisition broadens BioIVT’s capabilities in the in vitro diagnostics (IVD) space “by providing expanded control products and Keystone Biologicals’ expertise in the collection of bulk units of disease-state and normal sera and plasma.”

Following the transaction – financial terms of which were not disclosed – Keystone Biologicals will become part of the BioIVT organization.

With the addition, BioIVT will provide ‘comprehensive’ solutions, including remnant biofluids and tissues for early drug development, clinical specimens and point-of-care services for validation studies, and disease-state plasma collected as bulk units to support IVD manufacturing requirements, said Noah.

“When it comes to diagnostic kit development and manufacturing, IVD researchers need a reliable source for control and calibrator plasma and sera,”​ she added.

Little change will be seen in the early phases of integration, though as the companies fully merge, Noah said, “we will be looking to drive operational efficiencies and customer service processes that will serve to enhance the client experience.”

BioIVT – formerly BioreclamationIVT – has made several acquisitions over the last couple years, and standardized its site processes​ to manage clinical trial data at all of its locations.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more